title: Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen.
abstract: The potential benefits of skin delivery of vaccines derive from the presence of a densely connected network of antigen presenting cells in the skin layer, most significantly represented by Langerhans cells and dermal dendritic cells. Targeting these cells by adjuvant conjugated to an antigen should result in enhanced immunogenicity of a vaccine. Since one of the most widely used adjuvants is an insoluble salt of aluminum (aluminum hydroxide) that cannot be used for skin delivery due to reactogenicity, we focused our attention on agonists of receptors present on skin dendritic cells, including the Dectin-1 receptor. β-(1-3)-glucans, which are the most abundant components of the fungal surface, are known to activate the innate immune response by interaction with the C-type lectin-like Dectin-1 receptor. In this work we identified by rational design a well-defined synthetic β-(1-3)-glucan hexasaccharide as a Dectin-1 agonist and chemically conjugated it to the genetically detoxified diphtheria toxin (CRM197) protein antigen, as a means to increase the binding to Dectin-1 receptor and to target to skin dendritic cells. We demonstrated that the in vitro activation of the receptor was significantly impacted by the presentation of the glucan on the protein carrier. In vivo results in mice showed that the conjugation of the synthetic β-(1-3)-glucan when delivered intradermally resulted in higher antibody titers in comparison to intramuscular (i.m.) immunization and was not different from subcutaneous (s.c.) delivery. These findings suggest that weak receptor binders can be turned into more potent agonists by the multivalent presentation of many ligands covalently conjugated to the protein core. Moreover, this approach is particularly valuable to increase the immunogenicity of antigens administered via skin delivery.
authors: Agnese
authors: A
authors: Donadei
authors: Simona
authors: S
authors: Gallorini
authors: Francesco
authors: F
authors: Berti
authors: Derek T
authors: DT
authors: O'Hagan
authors: Roberto
authors: R
authors: Adamo
authors: Barbara C
authors: BC
authors: Baudner
mesh_terms: D000276:Adjuvants, Immunologic / Q000737:chemistry; D000818:Animals; D000941:Antigens / Q000737:chemistry*; D002460:Cell Line; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D037181:Lectins, C-Type / Q000737:chemistry*; D051379:Mice; D008807:Mice, Inbred BALB C; D047071:beta-Glucans / Q000819:agonists / Q000737:chemistry*; D000099181:Dectin-1
chemical_list: D000276:Adjuvants, Immunologic; D000941:Antigens; D037181:Lectins, C-Type; D047071:beta-Glucans; D000099181:Dectin-1
keywords: adjuvant conjugation; dectin-1 targeting; glycoconjugates; skin delivery; β-glucans